Correction: Adenosine A1 receptors promote vasa vasorum endothelial cell barrier integrity via Gi and akt-dependent actin cytoskeleton remodeling (PLoS ONE, 8, 4 (e59733) DOI: 10.1371/journal.pone.0059733);Adenosine A1 Receptors Promote Vasa Vasorum Endothelial Cell Barrier Integrity via Gi and Akt-Dependent Actin Cytoskeleton Remodeling

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Siddaramappa Umapathy, Nagavedi ^a,b   Kaczmarek, Elzbieta ^c   Fatteh, Nooreen ^a   Burns, Nana ^d   Lucas, Rudolf ^a,b   Stenmark, Kurt R ^d   Verin, Alexander D ^a,b   Gerasimovskaya, Evgenia V ^d  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b AUGUSTA UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 [2 (4 AMINO 1,2,5 OXADIAZOL 3 YL) 1 ETHYL 7 (3 PIPERIDINYLMETHOXY) 1H IMIDAZO[4,5 C]PYRIDIN 4 YL] 2 METHYL 3 BUTYN 2 OL; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ADENOSINE A1 RECEPTOR GENE; ADENOSINE A2A RECEPTOR GENE; ADENOSINE A2B RECEPTOR GENE; ADENOSINE A3 RECEPTOR GENE; ANIMAL CELL; ARTICLE; CALF (MAMMAL); CELL HYPOXIA; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; MALE; MICROTUBULE ASSEMBLY; MOLECULAR DYNAMICS; NEWBORN; NONHUMAN; PERMEABILITY BARRIER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY ARTERY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASA VASORUM ENDOTHELIUM CELL;

EID: 84876191136     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/annotation/42ab28e5-36fe-4a5f-b6aa-5cfec1bf2e63     Document Type: Erratum

References (71)

1. Stenmark KR, Fagan KA, Frid MG, (2006) Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 99: 675-691.
2. Stenmark KR, Aldashev AA, Orton EC, Durmowicz AG, Badesch DB, et al. (1991) Cellular adaptation during chronic neonatal hypoxic pulmonary hypertension. Am J Physiol 261: 97-104.
3. Tuder RM, Groves B, Badesch DB, Voelkel NF, (1994) Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 144: 275-285.
4. Maggiorini M, (2006) High altitude-induced pulmonary oedema. Cardiovasc Res 72: 41-50.
5. Tuder RM, Yun JH, Bhunia A, Fijalkowska I, (2007) Hypoxia and chronic lung disease. J Mol Med (Berl) 85: 1317-1324.
6. Sahara M, Sata M, Morita T, Nakamura K, Hirata Y, et al. (2007) Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Circulation 115: 509-517.
7. Barger AC, Beeuwkes R 3rd, Lainey LL, Silverman KJ (1984) Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 310: 175-177.
8. Hayden MR, Tyagi SC, (2004) Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation. Cardiovasc Diabetol 3: 1.
9. Gerasimovskaya EV, Woodward HN, Tucker DA, Stenmark KR, (2008) Extracellular ATP is a pro-angiogenic factor for pulmonary artery vasa vasorum endothelial cells. Angiogenesis 11: 169-182.
10. Frid MG, Brunetti JA, Burke DL, Carpenter TC, Davie NJ, et al. (2006) Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 168: 659-669.
11. Aird WC, (2007) Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 100: 174-190.
12. Aird WC, (2007) Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100: 158-173.
13. Mulligan MS, Vaporciyan AA, Miyasaka M, Tamatani T, Ward PA, (1993) Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol 142: 1739-1749.
14. Erlinge D, Burnstock G, (2008) P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4: 1-20.
15. Kolosova IA, Mirzapoiazova T, Adyshev D, Usatyuk P, Romer LH, et al. (2005) Signaling pathways involved in adenosine triphosphate-induced endothelial cell barrier enhancement. Circ Res 97: 115-124.
16. Umapathy NS, Fan Z, Zemskov EA, Alieva IB, Black SM, et al. (2010) Molecular mechanisms involved in adenosine-induced endothelial cell barrier enhancement. Vascul Pharmacol 52: 199-206.
17. Burnstock G, (2006) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58: 58-86.
18. Woodward HN, Anwar A, Riddle S, Taraseviciene-Stewart L, Fragoso M, et al. (2009) PI3K, Rho, and ROCK play a key role in hypoxia-induced ATP release and ATP-stimulated angiogenic responses in pulmonary artery vasa vasorum endothelial cells. Am J Physiol Lung Cell Mol Physiol 297: L954-964.
19. Hasko G, Cronstein BN, (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25: 33-39.
20. Zimmermann H, (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362: 299-309.
21. Eltzschig HK, Thompson LF, Karhausen J, Cotta RJ, Ibla JC, et al. (2004) Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104: 3986-3992.
22. Thompson LF, Eltzschig HK, Ibla JC, Van De Wiele CJ, Resta R, et al. (2004) Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 200: 1395-1405.
23. Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J, (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-552.
24. Linden J, (2001) Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41: 775-787.
25. Merighi S, Mirandola P, Varani K, Gessi S, Leung E, et al. (2003) A glance at adenosine receptors: novel target for antitumor therapy. Pharmacol Ther 100: 31-48.
26. Srinivas SP, Satpathy M, Gallagher P, Lariviere E, Van Driessche W, (2004) Adenosine induces dephosphorylation of myosin II regulatory light chain in cultured bovine corneal endothelial cells. Exp Eye Res 79: 543-551.
27. Gessi S, Merighi S, Fazzi D, Stefanelli A, Varani K, et al. (2011) Adenosine receptor targeting in health and disease. Expert Opin Investig Drugs 20: 1591-1609.
28. Paty PS, Sherman PF, Shepard JM, Malik AB, Kaplan JE, (1992) Role of adenosine in platelet-mediated reduction in pulmonary vascular permeability. Am J Physiol 262: H771-777.
29. Tilley SL, Wagoner VA, Salvatore CA, Jacobson MA, Koller BH, (2000) Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J Clin Invest 105: 361-367.
30. Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, et al. (2008) A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111: 2024-2035.
31. Henttinen T, Jalkanen S, Yegutkin GG, (2003) Adherent leukocytes prevent adenosine formation and impair endothelial barrier function by Ecto-5′-nucleotidase/CD73-dependent mechanism. J Biol Chem 278: 24888-24895.
32. Eltzschig HK, Ibla JC, Furuta GT, Leonard MO, Jacobson KA, et al. (2003) Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198: 783-796.
33. Narravula S, Lennon PF, Mueller BU, Colgan SP, (2000) Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function. J Immunol 165: 5262-5268.
34. Hasegawa T, Bouis D, Liao H, Visovatti SH, Pinsky DJ, (2008) Ecto-5′ nucleotidase (CD73)-mediated adenosine generation and signaling in murine cardiac allograft vasculopathy. Circ Res 103: 1410-1421.
35. Morote-Garcia JC, Rosenberger P, Kuhlicke J, Eltzschig HK, (2008) HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111: 5571-5580.
36. Umapathy NS, Zemskov EA, Gonzales J, Gorshkov BA, Sridhar S, et al. (2010) Extracellular beta-nicotinamide adenine dinucleotide (beta-NAD) promotes the endothelial cell barrier integrity via PKA- and EPAC1/Rac1-dependent actin cytoskeleton rearrangement. J Cell Physiol 223: 215-223.
37. Birukova AA, Smurova K, Birukov KG, Kaibuchi K, Garcia JG, et al. (2004) Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction. Microvasc Res 67: 64-77.
38. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
39. Liu F, Schaphorst KL, Verin AD, Jacobs K, Birukova A, et al. (2002) Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3beta. FASEB J 16: 950-962.
40. Garcia JG, Schaphorst KL, (1995) Regulation of endothelial cell gap formation and paracellular permeability. J Investig Med 43: 117-126.
41. Verin AD, Patterson CE, Day MA, Garcia JG, (1995) Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am J Physiol 269: L99-108.
42. Petrache I, Birukova A, Ramirez SI, Garcia JG, Verin AD, (2003) The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am J Respir Cell Mol Biol 28: 574-581.
43. Kiemer AK, Weber NC, Furst R, Bildner N, Kulhanek-Heinze S, et al. (2002) Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability. Circ Res 90: 874-881.
44. Friedl J, Puhlmann M, Bartlett DL, Libutti SK, Turner EN, et al. (2002) Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF. Blood 100: 1334-1339.
45. Frid MG, Li M, Gnanasekharan M, Burke DL, Fragoso M, et al. (2009) Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. Am J Physiol Lung Cell Mol Physiol 297: L1059-1072.
46. Wojciak-Stothard B, Tsang LY, Paleolog E, Hall SM, Haworth SG, (2006) Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 290: L1173-1182.
47. Jacobson JR, Dudek SM, Singleton PA, Kolosova IA, Verin AD, et al. (2006) Endothelial cell barrier enhancement by ATP is mediated by the small GTPase Rac and cortactin. Am J Physiol Lung Cell Mol Physiol 291: L289-295.
48. Lu Q, Harrington EO, Newton J, Casserly B, Radin G, et al. (2010) Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement. Am J Physiol Lung Cell Mol Physiol 298: L755-767.
49. Tsutsui S, Schnermann J, Noorbakhsh F, Henry S, Yong VW, et al. (2004) A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci 24: 1521-1529.
50. Park SW, Chen SW, Kim M, Brown KM, D'Agati VD, et al. (2010) Protection against acute kidney injury via A(1) adenosine receptor-mediated Akt activation reduces liver injury after liver ischemia and reperfusion in mice. J Pharmacol Exp Ther 333: 736-747.
51. Yildiz G, Demiryurek AT, Gumusel B, Lippton H, (2007) Ischemic preconditioning modulates ischemia-reperfusion injury in the rat lung: role of adenosine receptors. Eur J Pharmacol 556: 144-150.
52. Ngamsri KC, Wagner R, Vollmer I, Stark S, Reutershan J, (2010) Adenosine receptor A1 regulates polymorphonuclear cell trafficking and microvascular permeability in lipopolysaccharide-induced lung injury. J Immunol 185: 4374-4384.
53. Nakav S, Chaimovitz C, Sufaro Y, Lewis EC, Shaked G, et al. (2008) Anti-inflammatory preconditioning by agonists of adenosine A1 receptor. PLoS One 3: e2107.
54. Heller AR, Rothermel J, Weigand MA, Plaschke K, Schmeck J, et al. (2007) Adenosine A1 and A2 receptor agonists reduce endotoxin-induced cellular energy depletion and oedema formation in the lung. Eur J Anaesthesiol 24: 258-266.
55. Sayner SL, (2011) Emerging themes of cAMP regulation of the pulmonary endothelial barrier. Am J Physiol Lung Cell Mol Physiol 300: L667-678.
56. Singleton PA, Chatchavalvanich S, Fu P, Xing J, Birukova AA, et al. (2009) Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids. Circ Res 104: 978-986.
57. Birukova AA, Alekseeva E, Mikaelyan A, Birukov KG, (2007) HGF attenuates thrombin-induced endothelial permeability by Tiam1-mediated activation of the Rac pathway and by Tiam1/Rac-dependent inhibition of the Rho pathway. FASEB J 21: 2776-2786.
58. Xing J, Birukova AA, (2010) ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha. Microvasc Res 79: 56-62.
59. Budhiraja R, Tuder RM, Hassoun PM, (2004) Endothelial dysfunction in pulmonary hypertension. Circulation 109: 159-165.
60. Komarova Y, Malik AB, (2010) Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol 72: 463-493.
61. Mehta D, Malik AB, (2006) Signaling mechanisms regulating endothelial permeability. Physiol Rev 86: 279-367.
62. Vandenbroucke E, Mehta D, Minshall R, Malik AB, (2008) Regulation of endothelial junctional permeability. Ann N Y Acad Sci 1123: 134-145.
63. Yegutkin GG, Helenius M, Kaczmarek E, Burns N, Jalkanen S, et al. (2011) Chronic hypoxia impairs extracellular nucleotide metabolism and barrier function in pulmonary artery vasa vasorum endothelial cells. Angiogenesis 14: 503-513.
64. Finigan JH, Dudek SM, Singleton PA, Chiang ET, Jacobson JR, et al. (2005) Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J Biol Chem 280: 17286-17293.
65. Enomoto A, Murakami H, Asai N, Morone N, Watanabe T, et al. (2005) Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev Cell 9: 389-402.
66. Creighton J, Jian M, Sayner S, Alexeyev M, Insel PA, (2011) Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair. FASEB J 25: 3356-3365.
67. Taylor CT, Dzus AL, Colgan SP, (1998) Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha. Gastroenterology 114: 657-668.
68. Yu X, Deng L, Wang D, Li N, Chen X, et al. (2012) Mechanism of TNF-alpha autocrine effects in hypoxic cardiomyocytes: Initiated by hypoxia inducible factor 1alpha, presented by exosomes. J Mol Cell Cardiol 53: 848-857.
69. Liu FQ, Liu Y, Lui VC, Lamb JR, Tam PK, et al. (2008) Hypoxia modulates lipopolysaccharide induced TNF-alpha expression in murine macrophages. Exp Cell Res 314: 1327-1336.
70. Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, et al. (2010) Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 122: 920-927.
71. Rajsheker S, Manka D, Blomkalns AL, Chatterjee TK, Stoll LL, et al. (2010) Crosstalk between perivascular adipose tissue and blood vessels. Curr Opin Pharmacol 10: 191-196.